The SELUTION DeNovo Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3326 participants.
Also called NCT04859985
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,326 participants
- Sponsor
- Registry
-
NCT04859985
-
- Other papers using this trial's data
- Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Austria, Czechia, Finland, France, Germany, Italy, Netherlands, Poland, Singapore, Spain, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04859985. Randomized; no masking; primary purpose treatment. Start 2021-05-15 (actual); primary completion 2025-09-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The SELUTION DeNovo Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- SELUTION SLR
- Intervention (Device)
- DES
- Lead sponsor
- M.A. Med Alliance S.A.
Record details
- Record id
cardio:ct-nct04859985- Content hash
9c3c07424d9d27af47d322f165650c551ec6bf07e58a9c4aef8f2249894f1513